Article Details

AstraZeneca: Capivasertib Phase III Trial Meets Primary Goals - RTTNews

Retrieved on: 2022-10-26 23:42:07

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca: Capivasertib Phase III Trial Meets Primary Goals - RTTNews. View article details on hiswai:

Excerpt

British drug major AstraZeneca PLC (AZN.L) Wednesday announced positive high-level results from the CAPItello-291 Phase III trial of capivasertib ...

Article found on: www.rttnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up